Clinical outcome and biological characteristics of Chronic Myeloid Leukemia patients treated with nilotinib front-line
The present work reports the outcome of the GIMEMA CML WP study CML0811, an independent trial investigating nilotinib as front-line treatment in chronic phase chronic myeloid leukemia (CML). Moreover, the results of the proteomic analysis of the CD34+ cells collected at CML diagnosis, compared to th...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Doctoral Thesis |
| Language: | en |
| Published: |
Alma Mater Studiorum - Università di Bologna
2015
|
| Subjects: | |
| Online Access: | http://amsdottorato.unibo.it/6760/ |